Outcomes After Vitrectomy in Eyes With Tractional Diabetic Macular Edema - Trial NCT06316388
Access comprehensive clinical trial information for NCT06316388 through Pure Global AI's free database. This phase not specified trial is sponsored by Rehab Azzam and is currently Not yet recruiting. The study focuses on Diabetic Macular Edema. Target enrollment is 21 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Rehab Azzam
Assiut University
Timeline & Enrollment
N/A
Mar 10, 2024
Mar 11, 2025
Primary Outcome
assessment the outcomes of vitrectomy on retinal function in patients with tractional diabetic macular edema,assessment the outcomes of vitrectomy on retinal anatomy in patients with tractional diabetic macular edema
Summary
1. assessment the outcomes of vitrectomy on retinal function by mf-ERG (multifocal
 electroretinogram) and anatomy by OCT (optical coherence tomography) in patients with
 tractional diabetic macular edema (TDME) .
 
 2. To correlate the postoperative corrected distance visual acuity (CDVA) with the mf-ERG
 and OCT findings following vitrectomy surgery for TDME.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06316388
Non-Device Trial